Work

Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma

Year: 2006

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-05-2730

Authors: John D. Roberts, Mitchell R. Smith, Eric J. Feldman, Louise Cragg, Michael M. Millenson, Gail J. Roboz, Connie Honeycutt, Rose Thune, Kristin Padavic-Shaller, W. Hans Carter, Viswanathan Ramakrishnan, Anthony J. Murgo, Steven Grant

Institutions: VCU Massey Comprehensive Cancer Center, Fox Chase Cancer Center, Cornell University, Weill Cornell Medicine, Virginia Commonwealth University, Virginia Commonwealth University Medical Center, National Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: G1016094800, G150967332, G2585495816, G364506074, Promotion of Nucleoside Analog Induced Apoptosis by HDIs, General Clinical Research Center, PHASE I/LABORATORY STUDIES BRYOSTATIN/FLVDARA IN CLL/NHL, G7841399558, Comprehensive Cancer Center Program at Fox Chase, Massey Cancer Center - Cancer Center Support Grant

OpenAlex ID: W2071856972

FWCI: 2.038

Cites: 64

Cited by: 39

Related to: 10